In this interview, Sarah Manes, Global Liver Institute, explores the unique challenges faced by LGBTQI+ individuals, particularly those with disabilities, in accessing and receiving appropriate liver ...

On Thursday, the Food and Drug Administration announced its approval of the first ever therapeutic treatment targeting metabolic dysfunction-associated steatohepatitis (MASH). This represents a ...

New research calls for routine risk stratification of MASLD in people with obesity to detect and manage liver disease earlier ...

If you’ve recently found out you have liver cancer, you are probably feeling a range of emotions and have many questions. At Fred Hutchinson Cancer Center, we understand. We are here to help you find ...

The National Institute for Health and Health and Care Excellence (NICE) has recommended FibroScan, a non-invasive hepatic ultrasound scan, as an option for assessing liver damage from fibrosis and ...

Wearable data collection devices, combined with artificial intelligence, may help clinicians detect complications earlier and improve patient care.

Market research survey report underscores need to address gaps in care and early diagnosis of chronic liver disease and cirrhosis One of the challenges of chronic liver disease (CLD) is that its ...

The treatment of an enlarged liver depends on the underlying cause. In some cases, such as fatty liver disease, lifestyle changes such as weight loss, exercise, and a healthy diet can reverse the ...

Acute liver failure is a rare but life-threatening critical illness that occurs most often in patients who do not have preexisting liver disease. With an incidence of fewer than 10 cases per million ...

Mednow entered into a partnership agreement with HepCURE, one of Canada’s leading hepatitis C screening and treatment providers, to achieve the goal of eliminating hepatitis C in Canada by 2030. Liver ...